RESUMEN
In Argentina, hemolytic uremic syndrome (HUS) caused by Shiga toxin-producing Escherichia coli (STEC-HUS) infection is endemic, and reliable data about prevalence and risk factors have been available since 2000. However, information about STEC-associated bloody diarrhea (BD) is limited. A prospective study was performed during the period October 2018-June 2019 in seven tertiary-hospitals and 18 referral units from different regions, aiming to determine (i) the frequency of STEC-positive BD cases in 714 children aged 1-9 years of age and (ii) the rate of progression of bloody diarrhea to HUS. The number and regional distribution of STEC-HUS cases in the same hospitals and during the same period were also assessed. Twenty-nine (4.1%) of the BD patients were STEC-positive, as determined by the Shiga Toxin Quik Chek (STQC) test and/or the multiplex polymerase chain reaction (mPCR) assay. The highest frequencies were found in the Southern region (Neuquén, 8.7%; Bahía Blanca, 7.9%), in children between 12 and 23 month of age (8.8%), during summertime. Four (13.8%) cases progressed to HUS, three to nine days after diarrhea onset. Twenty-seven STEC-HUS in children under 5 years of age (77.8%) were enrolled, 51.9% were female; 44% were Stx-positive by STQC and all by mPCR. The most common serotypes were O157:H7 and O145:H28 and the prevalent genotypes, both among BD and HUS cases, were stx2a-only or -associated. Considering the endemic behavior of HUS and its high incidence, these data show that the rate of STEC-positive cases is low among BD patients. However, the early recognition of STEC-positive cases is important for patient monitoring and initiation of supportive treatment.
Asunto(s)
Infecciones por Escherichia coli , Síndrome Hemolítico-Urémico , Escherichia coli Shiga-Toxigénica , Niño , Humanos , Femenino , Preescolar , Lactante , Masculino , Escherichia coli Shiga-Toxigénica/genética , Infecciones por Escherichia coli/epidemiología , Argentina/epidemiología , Estudios Prospectivos , Diarrea/epidemiología , Síndrome Hemolítico-Urémico/epidemiologíaRESUMEN
Abstract Shiga toxin-producing Escherichia coli (STEC) are a heterogeneous group of foodborne pathogens causing a broad spectrum of human disease, from uncomplicated diarrhea to hemolytic uremic syndrome (HUS). In this study, we report an HUS case associated with an O59:NM H19 mstrain, harboring stx2a, iha, lpfAO26, lpfAO113 genes associated with STEC, and aatA, aap, pic, sigA, agg4A genes associated with enteroaggregative E. coli (EAEC), named Stx-EAEC. The strain showed low toxicity on Vero cells, and was resistant to streptomycin and trimethoprim/sulfonamides. The child carried the bacteria for more than 100 days. Since the large outbreak associated with Stx-EAEC O104:H4, many strains with similar profiles have been described. In Germany, an O59:NM[H19] strain, with comparable characteristics to the Argentine strain, was isolated from a bloody diarrhea case. In Argentina, this is the first report of an HUS case associated with a Stx-EAEC infection, and represents a new challenge for the surveillance system. © 2019 Published by Elsevier Espana, S.L.U. on behalf of Asociacion Argentina de Microbiolog´a. This is an open access article under the CC BY-NC-ND license (https://creativecommons.org/ licenses/by-nc-nd/4.0/).
Resumen Escherichia coli productor de la toxina Shiga (STEC) es un grupo heterogéneo de patógenos transmitidos por alimentos que causan un amplio espectro de enfermedades humanas, desde diarrea no complicada hasta síndrome urémico hemolítico (SUH). Nosotros informamos de un caso de SUH por O59:NM[H19], que portaba los genes stx2a, iha, lpfAo26, lpfAoii3 asociados con STEC, y los genes aatA, aap, pic, sigA, agg4A de E. coli enteroagregativo (EAEC), llamado EAEC-Stx. La cepa mostró baja citotoxicidad en las células Vero, y fue resistente a estreptomicina y trimetoprima/sulfonamidas. El niño excretó la bacteria durante más de 100 días. Desde el brote asociado con EAEC-Stx O104:H4, se describieron muchas cepas con perfiles similares. En Alemania se aisló una cepa O59:NM[H19] de una diarrea sanguinolenta, con características comparables a la cepa argentina. Este es el primer informe de un caso de SUH asociado a una infección por EAEC-Stx, y representa un nuevo desafío para el sistema de vigilancia. © 2019 Publicado por Elsevier Espana, S.L.U. en nombre de Asociación Argentina de Microbiología. Este es un artículo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons. org/licenses/by-nc-nd/4.0/).
Asunto(s)
Niño , Humanos , Masculino , Escherichia coli Shiga-Toxigénica/aislamiento & purificación , Síndrome Hemolítico-Urémico/microbiología , ArgentinaRESUMEN
Shiga toxin-producing Escherichia coli (STEC) are a heterogeneous group of foodborne pathogens causing a broad spectrum of human disease, from uncomplicated diarrhea to hemolytic uremic syndrome (HUS). In this study, we report an HUS case associated with an O59:NM[H19] strain, harboring stx2a, iha, lpfAO26, lpfAO113 genes associated with STEC, and aatA, aap, pic, sigA, agg4A genes associated with enteroaggregative E. coli (EAEC), named Stx-EAEC. The strain showed low toxicity on Vero cells, and was resistant to streptomycin and trimethoprim/sulfonamides. The child carried the bacteria for more than 100 days. Since the large outbreak associated with Stx-EAEC O104:H4, many strains with similar profiles have been described. In Germany, an O59:NM[H19] strain, with comparable characteristics to the Argentine strain, was isolated from a bloody diarrhea case. In Argentina, this is the first report of an HUS case associated with a Stx-EAEC infection, and represents a new challenge for the surveillance system.
Asunto(s)
Síndrome Hemolítico-Urémico/microbiología , Escherichia coli Shiga-Toxigénica/aislamiento & purificación , Argentina , Niño , Humanos , MasculinoRESUMEN
BACKGROUND: Shiga toxin-producing Escherichia coli (STEC) is an important cause of bloody diarrhoea (BD), non-bloody diarrhoea (NBD) and the haemolytic uraemic syndrome (HUS). In Argentina and New Zealand, the most prevalent STEC serotype is O157:H7, which is responsible for the majority of HUS cases. In Australia, on the other hand, STEC O157:H7 is associated with a minority of HUS cases. The main aims of this study were to compare the phenotypic and genotypic characteristics of STEC O157 strains isolated between 1993 and 1996 from humans in Argentina, Australia and New Zealand, and to establish their clonal relatedness. RESULTS: Seventy-three O157 STEC strains, isolated from HUS (n = 36), BD (n = 20), NBD (n = 10), or unspecified conditions (n = 7) in Argentina, Australia and New Zealand, were analysed. The strains were confirmed to be E. coli O157 by biochemical tests and serotyping. A multiplex polymerase chain reaction (PCR) was used to amplify the stx1, stx2 and rfbO157 genes and a genotyping method based on PCR-RFLP was used to determine stx1 and stx2 variants. This analysis revealed that the most frequent stx genotypes were stx2/stx2c (vh-a) (91%) in Argentina, stx2 (89%) in New Zealand, and stx1/stx2 (30%) in Australia. No stx1-postive strains were identified in Argentina or New Zealand. All strains harboured the eae gene and 72 strains produced enterohaemolysin (EHEC-Hly). The clonal relatedness of strains was investigated by phage typing and pulsed-field gel electrophoresis (PFGE). The most frequent phage types (PT) identified in Argentinian, Australian, and New Zealand strains were PT49 (n = 12), PT14 (n = 9), and PT2 (n = 15), respectively. Forty-six different patterns were obtained by XbaI-PFGE; 37 strains were grouped in 10 clusters and 36 strains showed unique patterns. Most clusters could be further subdivided by BlnI-PFGE. CONCLUSION: STEC O157 strains isolated in Argentina, Australia, and New Zealand differed from each other in terms of stx-genotype and phage type. Additionally, no common PFGE patterns were found in strains isolated in the three countries. International collaborative studies of the type reported here are needed to detect and monitor potentially hypervirulent STEC clones.
Asunto(s)
Infecciones por Escherichia coli/microbiología , Escherichia coli O157/genética , Escherichia coli O157/metabolismo , Adhesinas Bacterianas/genética , Argentina , Australia , Proteínas Bacterianas/genética , Técnicas de Tipificación Bacteriana , Tipificación de Bacteriófagos , Análisis por Conglomerados , Dermatoglifia del ADN , ADN Bacteriano/genética , Electroforesis en Gel de Campo Pulsado , Escherichia coli O157/clasificación , Escherichia coli O157/aislamiento & purificación , Proteínas de Escherichia coli/biosíntesis , Proteínas de Escherichia coli/genética , Genotipo , Proteínas Hemolisinas/biosíntesis , Síndrome Hemolítico-Urémico/microbiología , Humanos , Epidemiología Molecular , Nueva Zelanda , Polimorfismo de Longitud del Fragmento de Restricción , Serotipificación , Toxina Shiga I/genética , Toxina Shiga II/genéticaRESUMEN
Escherichia coli productor de toxina Shiga (STEC) ha sido asociado con la etiopatogenia del síndrome urémico hemolítico (SUH). El objetivo fue caracterizar los casos de SUH observados en Mendoza y determinar su asociación con la infección por STEC. Entre el 1º de Julio de 1994 y el 30 de Junio de 1996 ingresaron al Hospital Pediátrico "Dr. HJ Notti", 36 pacientes con diagnóstico de SUH. La edad promedio fue de 22.8 meses, con un 44 por ciento en el sexo femenino. La enfermedad se estableció después de un perío
Asunto(s)
Humanos , Masculino , Femenino , Lactante , Preescolar , Niño , Síndrome Hemolítico-Urémico/microbiología , Infecciones por Escherichia coli/complicaciones , Toxinas Bacterianas , Escherichia coli , Síndrome Hemolítico-Urémico/epidemiología , Síndrome Hemolítico-Urémico/tratamiento farmacológico , Argentina , Estado Nutricional , Factores SocioeconómicosRESUMEN
Escherichia coli productor de toxina Shiga (STEC) ha sido asociado con la etiopatogenia del síndrome urémico hemolítico (SUH). El objetivo fue caracterizar los casos de SUH observados en Mendoza y determinar su asociación con la infección por STEC. Entre el 1º de Julio de 1994 y el 30 de Junio de 1996 ingresaron al Hospital Pediátrico "Dr. HJ Notti", 36 pacientes con diagnóstico de SUH. La edad promedio fue de 22.8 meses, con un 44 por ciento en el sexo femenino. La enfermedad se estableció después de un período prodrómico de 4.5 días, el 94.4 por ciento de los pacientes presentó diarrea siendo sanguinolenta en el 83.3 por ciento de los casos. El 69.4 por ciento recibió antibioticoterapia antes de su ingreso. Los casos se presentaron fundamentalmente en niños eutróficos (88.9 por ciento), de condición socioeconómica media-baja (91.7 por ciento) de origem urbano (72.2 por ciento), durante el verano y principios de otoño. En el período de estado los pacientes presentaron palidez (100 por ciento), edema (25 por ciento), anuria (38.9 por ciento), oliguria (41.7 por ciento), anemia hemolítica (97.2 por ciento), trombocitopenia (86.1 por ciento) y compromiso neurológico (41.7 por ciento). Veinticinco pacientes presentaron formas completas de SUH. El 50 por ciento de los pacientes fue dializado y el 88.9 por ciento requirió transfusión de sedimento globular. El promedio de días de internación fue de 15.1. El 91.7 por ciento de los pacientes recuperó la función renal, dos pacientes evolucionaron a insuficiencia renal crónica y uno falleció. Evidencias acumulativas de infección por STEC se encontraron en 19 (86.4 por ciento) de 22 pacientes, STEC del serotipo 0157:H7, biotipo C fue detectado en 8 casos (36.4 por ciento). Stx2 fue la citotoxina prevalente en STEC, en materia fecal (STMF) y anticuerpos a-Stx.